Market Report on Biologics Industry

July 04th 2016 Mumbai, India: Bharatbook.com announces a report on “Market Report on Biologics Industry". The report serves as a guide to Biologics industry, covering more than 1000 companies that are engaged in Biologics products and services.

This report on Biologics gives a market insight into products types including Monoclonal Antibodies, Blood & Blood Products, Vaccines, Insulin and Other, for both human and animal consumption. Market projections and estimates are illustrated by region and by type. The report serves as a guide to Biologics industry, covering more than 1000 companies that are engaged in Biologics products and services. Major Contract Research Organizations, Research Institutes and Universities serving the Animal Biologics industry are also covered in the corporate directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is covered in the report. Compilation of Worldwide Patents related to Biologic products is also provided. A global perspective is presented along with regional analysis covering the regions of North America, Europe, Asia-Pacific, and Rest of World with 165 exclusive graphically represented exhibits.

Global Biologics Value Market is projected to grow about 9% compounded annually from 2010 through 2022. North America is projected to occupy about 50% of the total global market. Blood and blood products are the major product area with tremendous potential and growth. Automated blood collection and processing systems as well as prior-screening capabilities of latest assays are expected to enhance quantity and quality of blood. Since the last decade, the therapeutic market for monoclonal antibodies has grown exponentially. Bevacizumab, trastuzumab, adalimumab, infliximab and rituximab are the top five therapeutic antibodies available. About 40% of the best selling biopharmaceuticals are therapeutic monoclonal antibodies....